» Articles » PMID: 29056912

Luteolin: A Flavonoid That Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms

Overview
Journal Front Pharmacol
Date 2017 Oct 24
PMID 29056912
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease (CVD) has become the leading cause of morbidity and mortality worldwide. A well-monitored diet with a sufficient intake of fruits and vegetables has been confirmed as a primary prevention of CVD. Plant constituents such as flavonoids have been shown to confer healthy benefits. Luteolin (Lut), a kind of flavonoid, possesses anti-oxidative, anti-tumor, and anti-inflammatory properties. Recent scientific literature has reported the cardiac protective effects of Lut and . Therefore, the aim of this review is to provide an update and detailed overview with cardio-protective molecular mechanisms of Lut with a focus on multiple intrinsic and extrinsic effectors. We further explore how these mechanisms participate in ischemia/reperfusion (I/R) injury, heart failure (HF) and atherosclerosis (AS). A proper understanding of the cardiovascular protective effects and the relative mechanisms of Lut may provide the possibility of new drug design and development for CVD. With the previous studies mainly focused on basic research, we need to advance the prospects of its further clinical utilization against CVD, large prospective clinical trials of Lut are needed to observe its therapeutic effects on patients with I/R injury, HF and AS, especially on the effective therapeutic dosage, and safety of long-term administration.

Citing Articles

Associations between oxidative balance scores and heart failure among americans: NHANES (2007-2018).

Xu X, Wang X, Han X BMC Cardiovasc Disord. 2025; 25(1):41.

PMID: 39849357 PMC: 11756190. DOI: 10.1186/s12872-024-04456-z.


The therapeutic potential of Honeysuckle in cardiovascular disease: an anti-inflammatory intervention strategy.

Zhao Y, Zhang J, Lu F, Xu W, Ma Q, Hu J Am J Transl Res. 2025; 16(12):7262-7277.

PMID: 39822489 PMC: 11733370. DOI: 10.62347/NJMJ7853.


Antimicrobial and Antibiofilm Activity of Extracts Obtained by Supercritical Fluid Extraction Under Various Extraction Conditions.

Gwiazdowska D, Waskiewicz A, Jus K, Marchwinska K, Frak S, Popowski D Molecules. 2025; 29(24.

PMID: 39769912 PMC: 11676637. DOI: 10.3390/molecules29245823.


Nutritional and Nutraceutical Support to the Failing Myocardium: A Possible Way of Potentiating the Current Treatment of Heart Failure.

Macri R, Mollace R, Serra M, Scarano F, Ritorto G, Ussia S Int J Mol Sci. 2024; 25(22).

PMID: 39596298 PMC: 11594499. DOI: 10.3390/ijms252212232.


Identifying Hub Genes and Metabolic Pathways in Collagen VI-Related Dystrophies: A Roadmap to Therapeutic Intervention.

Ceyhan A, Kaynar A, Altay O, Zhang C, Temel S, Turkez H Biomolecules. 2024; 14(11).

PMID: 39595553 PMC: 11592009. DOI: 10.3390/biom14111376.


References
1.
Braunwald E . The war against heart failure: the Lancet lecture. Lancet. 2014; 385(9970):812-24. DOI: 10.1016/S0140-6736(14)61889-4. View

2.
Rosenkranz S . TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 2004; 63(3):423-32. DOI: 10.1016/j.cardiores.2004.04.030. View

3.
Werner C, Bohm M . The therapeutic role of RAS blockade in chronic heart failure. Ther Adv Cardiovasc Dis. 2009; 2(3):167-77. DOI: 10.1177/1753944708091777. View

4.
Motohashi H, Yamamoto M . Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004; 10(11):549-57. DOI: 10.1016/j.molmed.2004.09.003. View

5.
Ha T, Hua F, Liu X, Ma J, McMullen J, Shioi T . Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc Res. 2008; 78(3):546-53. DOI: 10.1093/cvr/cvn037. View